OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's principal products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSw⦠read more
Healthcare
Medical Instruments & Supplies
36 years
USD
Exclusive to Premium users
$2.76
Price-0.36%
-$0.01
$201.858m
Small
-
Premium
Premium
-
EBITDA Margin-
Net Profit Margin-
Free Cash Flow Margin$38.674m
-
1y CAGR-
3y CAGR-
5y CAGR-$51.034m
-
1y CAGR-
3y CAGR-
5y CAGR-$0.67
-
1y CAGR-
3y CAGR-
5y CAGR$380.721m
$445.040k
Assets$64.314m
Liabilities-
Debt0.00%
-
Debt to EBITDA$12.158m
-
1y CAGR-
3y CAGR-
5y CAGR